Molecular Oncology Committee

To advance the practice of Molecular Oncology diagnostics by:

1. Coordinating scientific resources involved in molecular diagnostics.
2. Monitoring the current state of the field and incorporating new modalities and clinical applications into laboratory practice.
3. Developing, maintaining, and enhancing clinically relevant proficiency testing and educational programs in the field of molecular oncology.
4. Disseminating proficiency performance data and supporting the development of evidence-based guidelines to promote laboratory excellence and quality patience care.
5. Reviewing and providing feedback on public policy as it applies to the practice of molecular pathology.

This committee reports to the Council on Scientific Affairs. View a list of the Current Committee Members and find additional resources and information in the Molecular Oncology Topic Center.
 

Activities of Committee

• Create and support state of the art Proficiency Testing Programs, through sample preparation, formulating a questionnaire, data review, and critique development.
• Work with highly skilled Washington, DC, staff on regulatory issues.
• Develop educational seminars and adjuncts for the CAP National Meetings.
• Work in support of CAP Laboratory Accreditation Program requirements for molecular pathology and genetics.
• Work on special projects (eg, research studies, manuscript summarizing our experience with proficiency surveys, or describing our practice recommendations).

Expertise or Experience

• Working knowledge of molecular oncology practice, technology, and clinical applications
• Strong interest in promoting molecular oncology
• Ability to provide tools for the community pathologist to guide their practice of molecular pathology

Benefits of Committee Membership

• Interact with colleagues on state of the art technology and practice issues
• Gain knowledge about regulatory and financial aspects of pathology practice
• Learn through research and educational projects
• Share ideas and protocols with colleagues around the country

Representation on Committee Beyond the CAP

• Two liaisons, one from Association for Molecular Pathology and one from American Association of Clinical Chemistry